Onconetix Revenue

In the year 2025, Onconetix had annual revenue of $815.37K, down -67.70%. Onconetix had revenue of $303.60K in the quarter ending December 31, 2025, a decrease of -57.36%.

Revenue (ttm)

$815.37K

Revenue Growth

-67.70%

P/S Ratio

1.10

Revenue / Employee

$407,686

Employees

Market Cap

796.87K

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	815.37K	-1.71M	-67.70%
Dec 31, 2024	2.52M	2.47M	4,217.31%
Dec 31, 2023	58.47K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ONCO News

6 days ago - Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update - GlobeNewsWire
8 days ago - Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors - GlobeNewsWire
14 days ago - Onconetix Highlights Realbotix's Role in Ericsson's World-First 6G Trial Demonstration - GlobeNewsWire
16 days ago - Onconetix, Inc. Announces 1-for-5 Reverse Stock Split - GlobeNewsWire
7 weeks ago - Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company - GlobeNewsWire
7 weeks ago - Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer - Business Wire
6 months ago - Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. - GlobeNewsWire
6 months ago - Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement - GlobeNewsWire

More News